Inhibition of Protein S by Autoantibodies in Patients with Acquired Protein S Deficiency

Summary

This study was undertaken to analyze antibodies to protein S (PS) in patients with an acquired PS deficiency. Plasma from symptomatic patients with acquired (n = 14) or congenital (n = 10) PS deficiency and 10 healthy donors was screened for PS antibodies by immunoblotting and for anti-phospholipid antibodies. PS antibodies (IgG) were detected in five of the patients with acquired PS deficiency. These antibodies belonged to the G1 and G4 immunoglobulin subclasses. IgG fractions from the same 5 patients were shown to inhibit PS activity. The inhibition of PS activity by the 5 IgG fractions was shown to be time-and dose-dependent and was abolished following incubation with purified PS, while no effect was found after absorption with cardiolipin micelles. In addition, anticardiolipin monoclonal or human purified antibodies, failed to exert significant PS inhibition. These findings demonstrate that anti-PS antibodies are able to inhibit PS activity and that this is independent of anti-phospholipid antibodies. Given the clinical features of the patients, these antibodies should be regarded as an expression of the broad autoimmune syndrome involving the phospholipid-binding plasma proteins.

• References

• 1 Walcher FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-5524
• 2 Fair DS, Marlar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67: 1168-1171
• 3 Fair DS, Marlar RA. Biosynthesis and secretion of Factor VII, Protein C, Protein S and Protein C inhibitor from a human hepatoma cell line. Blood 1986; 67: 64-70
• 4 Schwarz HP, Heeb MJ, Wencel-Drake JD, Griffin JH. Identification and quantitation of Protein S in human platelets. Blood 1985; 66: 1452-1455
• 5 Dahlbäck B. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 1983; 209: 847-856
• 6 Comp PC, Nixon RR, Cooper MR, Esmon CT. Familiar protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-2088
• 7 Schwartz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familiar thrombotic disease. Blood 1984; 64: 1297-1300
• 8 Bertina RM, Ploos van Amstel HK, van Wijngaarden A, Coenen J, Leemhuis MP, Deutz-Terlouw PP, van der Linden IK, Reitsma PH. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460. Blood 1990; 76: 538-548
• 9 Comp PC, Thumau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood 1986; 68: 881-855
• 10 Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood 1987; 69: 692-694
• 11 D’Angelo AD, Viganò-D’Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 1988; 81: 1445-1454
• 12 Viganò-D’Angelo S, D’Angelo AD, Kaufman CE, Scholer C, Esmon CT, Comp PC. Protein S deficiency occurs in the nephrotic syndrome. Ann Int Med 1987; 107: 42-47
• 13 Keeling DM, Campbell SJ, Mackie IJ, Machin SJ, Isenberg DA. Total and free protein S in systemic lupus erythematosus. Thromb Res 1990; 60: 237-240
• 14 Chafa O, Fischer AM, Meriane F, Chellali T, Sternberg C, Otmani F, Benabadji M. Behçet syndrome associated with protein S deficiency. Thromb Haemost 1992; 67: 1-3
• 15 Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, Gastaut JA, Juhan-Vague I. Protein S deficiency and HIV infection. N Engl J Med 1991 324. 1220 (letter).
• 16 Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immune deficiency virus infection. Blood 1993; 81: 1801-1807
• 17 Sorice M, Griggi T, Arcieri P, Circella A, d’Agostino F, Ranieri M, Modrzweska R, Lenti L, Mariani G. Protein S and HIV infection. The role of anticardiolipin and antiprotein S antibodies. Thromb Res 1994; 73: 165-175
• 18 Lafeuillade A, Sorice M, Griggi T, Pellegrino P, Geoffroy M, Profizi N. Role of Autoimmunity in Protein S Deficiency during HIV-1 Infection. Infection 1994; 22: 201-203
• 19 Malia RG, Kitchen S, Greaves M, Preston FE. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies. Br J Haematol 1990; 76: 101-107
• 20 Marciniak E, Romond E. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 1989; 74: 2426-2432
• 21 Oosting JD, Derksen RHWM, Bobbink IWG, Hackeng TM, Bouma BN, de Groot PG. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood 1993; 81: 2618-2625
• 22 Ruits-Arguelles GJ, Ruits-Arguelles A, Perez-Romano B, Alarcon-Segovia D. Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol. Acta Haematol 1993; 89: 206-208
• 23 D’Angelo A, Della Valle P, Crippa L, Pattarini E, Grimaldi LME, Vigano D’Angelo S. Autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med 1993; 328: 1753-1757
• 24 Sorice M, Griggi T, Circella A, Lenti L, Arcieri P, Di Nucci GD, Mariani G. Protein S antibodies in acquired protein S deficiencies. Blood 1994; 83: 2383-2384
• 25 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-688
• 26 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350-4360
• 27 Triplett DA, Brand J. Laboratory identification of Lupus Anticoagulant. Br J Haematol 1989; 73: 139-142
• 28 Harris EN. The Second International Anti-Cardiolipin Standardization Workshop/ The Kaps Group. Am J Clin Pathol 1990; 94: 476-484
• 29 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phonol reagent. J Biol Chem 1951; 193: 265-275
• 30 Harris EN, Gharavi AE, Loizou S. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16: 1-6
• 31 Ichikawa K, Suzuki T, Hashimoto Y, Sumida T, Tomioka H, Yoshida S Koike T. Monoclonal autoantibodies to cardiolipin derived from SLE mice. Lupus 1992; 138: 239-247
• 32 Me Neil HP, Krillis SA, Chesterman CN. Purification of antiphospholipid antibodies using a new affinity method. Thromb Res 1988; 52: 641-648
• 33 Me Neil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Β₂-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
• 34 Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when Β₂-Glycoprotein I is bound to a suitable surface. Thromb Haemost 1995; 73: 29-34
• 35 Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA. Lupus anticoagulant IgG’s (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632
• 36 Vermylen J, Amout J. Is the antiphospholipid syndrome caused by antibodies directed against physiological relevant phospholipid-protein complexes?. J Lab Clin Med 1992; 120: 10-12
• 37 Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of Lupus Anticoagulants and other “antiphospholipid” autoantibodies. Blood 1994; 84: 2854-2867
• 38 Parke AL, Weinstein RE, Bona RD, Maier DB, Walcher FJ. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med 1992; 93: 49-56
• 39 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of Protein S to factor Va associated with inhibition of prothrombinase that is independent of activated Protein C. J Biol Chem 1993; 268: 2872-2877